IL17A and viral myocarditis: Overall, the immunopathogenesis role of Th17 cells mediating viral myocarditis has been each more well stablished, and the blockade of IL-17 per si or IL-17-induced pathways represent a promising new therapeutic approach in the therapy of viral myocarditis diseases.